PS
EW icon

PayPay Securities’s Edwards Lifesciences EW Stock Holding History

PayPay Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Sell
12
-1
-8% -$84 0.03% 220
2026
Q1 		$1.03K Sell
13
-5
-28% -$412 0.04% 245
2025
Q4 		$1.53K Buy
18
+4
+29% +$328 0.05% 197
2025
Q3 		$1.13K Sell
14
-6
-30% -$469 0.04% 206
2025
Q2 		$1.56K Sell
20
-3
-13% -$224 0.08% 173
2025
Q1 		$1.73K Sell
23
-12
-34% -$859 0.1% 168
2024
Q4 		$2.59K Buy
+35
New +$2.45K 0.11% 150

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

PayPay Securities's EW Position: Q2 2026 in Review

PayPay Securities reduced its Edwards Lifesciences (EW) stake by 7.7% in Q2 2026, selling an estimated $84 and leaving 12 shares worth $1.09K. The position accounts for 0.03% of the portfolio, ranked #220.

PayPay Securities first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.59K in Q4 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • PayPay Securities held 12 shares of Edwards Lifesciences worth $1.09K as of Q2 2026.
  • PayPay Securities sold 1 Edwards Lifesciences share in Q2 2026, an estimated $84.
  • Edwards Lifesciences made up 0.03% of PayPay Securities's portfolio in Q2 2026, its #220 holding.
  • PayPay Securities first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • PayPay Securities's Edwards Lifesciences position peaked at $2.59K in Q4 2024.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.